Authors
Loading...
Randomized trial examines sphingolipids' role in insulin resistance and inflammation in obese individuals with liver disease, suggesting a crucial relationship.
Apostolopoulou et al. (2018) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: